Recent Quotes (30 days)

You have no recent quotes
chg | %

AstraZeneca plc news

   Watch this stock
Showing stories 11 - 20 of about 188   

Articles published

AZN 4,460.00 +35.00 (0.79%)
price chart
Why I Would Buy Bioventix Plc Over GlaxoSmithkline Plc And AstraZeneca Plc
Investing in the world of small caps can be a hazardous occupation: it comes with a serious wealth warning. It is hardly surprising to find that most investors place their money into large and mid-cap companies - on the whole these stocks can be a lot ...
AstraZeneca PLC (ADR) (NYSE:AZN) on Watch  Street Report
Why Does GlaxoSmithKline plc Yield So Much More Than AstraZeneca plc?
These two British drugs behemoths are similar businesses that both pay big dividends, and they've mostly tended to move in lockstep.
AstraZeneca plc 9.7% Potential Upside Indicated by Barclays Capital
AstraZeneca plc using EPIC code LON:AZN has had its stock rating noted as 'Reiterates' with the recommendation being set at 'UNDERWEIGHT' today by analysts at Barclays Capital.
AstraZeneca plc Given "Outperform" Rating at BNP Paribas (AZN)  Dakota Financial News
Deutsche Bank Reaffirms "Hold" Rating for AstraZeneca plc (AZN)  sleekmoney
General Report on AstraZeneca PLC (ADR) (NYSE:AZN)
[Bloomberg] AstraZeneca PLC (ADR) (NYSE:AZN)(TREND ANALYSIS) treatment for heartburn attracted the most spending of any single drug under Medicare's drug benefit program, making up 2.4 percent of expenses.
AstraZeneca plc Receives $77.00 Average PT from Brokerages (NYSE:AZN)  The Legacy
News Review- AstraZeneca plc (ADR) (AZN), General Dynamics Corporation ...  Investor Wired
Shire Plc Has Outperformed AstraZeneca plc After Acquisition Bids For Both ...
In 2014, the pharmaceutical sector saw two potential mega mergers fail, as a result of new tax rules enacted to sharply limit tax inversion arrangements which have become rampant in the US.
Johnson & Johnson (JNJ), AstraZeneca plc (ADR), Eli Lilly and Co: New ...
The US Food and Drug Administration (FDA) issued a warning on Friday that a new class of type 2 diabetes drugs, called sodium-glucose contransporter-2 (SGLT2) inhibitors, may carry an additional risk of ketoacidosis - a potentially lethal condition if ...
FDA Warns Of Diabetes Drugs From AstraZeneca, Janssen  Law360 (subscription)
AstraZeneca plc Earns Outperform Rating from BNP Paribas (AZN)
Finally, BNP Paribas reiterated its outperform rating on shares of SABMiller plc. They have a GBX 4,000 ($61.78) price target on that stock.
AstraZeneca plc (ADR), Novartis AG Combo Melanoma Drug Deemed Safe In ...
AstraZeneca plc (ADR) (NYSE:AZN) and Novartis AG (ADR) (NYSE:NVS) have partnered up to develop a three-drug combination treatment for a life-threatening form of skin cancer, melanoma.
AstraZeneca-Novartis Three-Drug Melanoma Treatment Found Safe
Recent Analysts' Ratings Changes for AstraZeneca plc (AZN)
4/29/2015 - AstraZeneca plc had its “buy” rating reaffirmed by analysts at Citigroup Inc.. They now have a GBX 5,400 ($81.84) price target on the stock.
Insider Buying: AstraZeneca plc insider Acquires �49005 in Stock (AZN)  WKRB News
AstraZeneca plc's Buy Rating Reiterated at Citigroup Inc. (AZN)  Mideast Time
AstraZeneca plc PT Lowered to GBX 5600 (AZN)
AstraZeneca plc logo Research analysts at Jefferies Group lowered their price target on shares of AstraZeneca plc (LON:AZN) from GBX 5,800 ($91.24) to GBX 5,600 ($88.09) in a report released on Thursday.